Effects of mGluR5 and mGluR1 antagonists on anxiety-like behavior and learning in developing rats

Behavioural Brain Research

Volumn 204, Issue 1, 2009, Pages 133-139

  Mikulecká, Anna ^a   Mareš, Pavel ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

AIDA; Anxiety; Immature rats; Learning; Metabotropic glutamate receptors; MPEP

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; LATENT PERIOD; LEARNING; LOCOMOTION; NONHUMAN; OPEN FIELD TEST; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

AGING; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; EXCITATORY AMINO ACID ANTAGONISTS; INDANS; LEARNING; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PYRIDINES; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; TIME FACTORS;

EID: 67849094100     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.05.032     Document Type: Article

References (44)

1. Altman J., Brunner R.L., Bulut F.G., and Sudarshan K. The development of behavior in normal and brain-damaged infant rats, studied with homing (nest-seeking) as motivation. In: Weiner A.V.N. (Ed). Drugs and the developing brain (1974), Plenum, New York 321-348
2. Altman J., and Sudarshan K. Postnatal development of locomotion in the laboratory rat. Anim Behav 23 (1975) 896-920
3. Anderson J.J., Bradbury M.J., Giracello D.R., Chapman D.F., Holtz G., Roppe J., et al. In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine. Eur J Pharmacol 473 (2003) 35-40
4. Ballard T.M., Woolley M.L., Prinssen E., Huwyler J., Porter R., and Spooren W. The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison. Psychopharmacology 179 (2005) 218-229
5. Campbell U.C., Lalwani K., Hernandez L., Kinney G.G., Conn P.J., and Bristow L.J. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. Psychopharmacology 175 (2004) 310-318
6. Cerbone A., and Sadile A.G. Behavioral habituation to spatial novelty: interference and noninterference studies. Neurosci Biobehav Rev 18 (1994) 497-518
7. Conn P.J. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann N Y Acad Sci 1003 (2003) 12-21
8. Costall B., Jones B.J., Kelly M.E., Naylor R.J., and Tomkins D.M. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32 (1989) 777-785
9. Crawley J.N. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15 (1981) 695-699
10. Crawley J.N., Skolnick P., and Paul S.M. Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse. Neuropharmacology 23 (1984) 531-537
11. Eichenbaum H. The hippocampus and mechanisms of declarative memory. Behav Brain Res 103 (1999) 123-133
12. File S.E., and Zangrossi Jr. H. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?. Psychopharmacology 110 (1993) 240-244
13. Forsgren L. Epidemiology and prognosis of epilepsy and its treatment. In: Shorvon S., Perucca E., Fish D., and Dodson E. (Eds). The treatment of epilepsy (2004), Blackwell, Oxford 21-24
14. Holson R.R., and Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol 14 (1992) 221-228
15. Homayoun H., Stefani M.R., Adams B.W., Tamagan G.D., and Moghaddam B. Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release. Neuropsychopharmacology 29 (2004) 1259-1269
16. Itoh J., Nabeshima T., and Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 101 (1990) 27-33
17. Klodzinska A., Tatarczynska E., Stachowicz K., and Chojnacka-Wojcik E. The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist. J Physiol Pharmacol 55 (2004) 113-126
18. Lea P.M., and Faden A.I. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev 12 (2006) 149-166
19. Lojková D., and Mareš P. Anticonvulsant action of an antagonist of metabotropic glutamate receptors mGluR5 MPEP in immature rats. Neuropharmacology 49 Suppl. 1 (2005) 219-229
20. Lojková-Janečková D., Ng J., and Mareš P. Antagonists of group I metabotropic glutamate receptors and cortical afterdischarges in immature rats. Epilepsia (2009)
21. Lopez-Bendito G., Shigemoto R., Fairen A., and Lujan R. Differential distribution of group I metabotropic glutamate receptors during rat cortical development. Cereb Cortex 12 (2002) 625-638
22. Mareš P. Age-dependent anticonvulsant action of antagonists of group I glutamate metabotropic receptors in rats. Epilepsy Res 83 (2009) 215-223
23. Mareš P., and Mikulecká A. MPEP, an antagonist of metabotropic glutamate receptors, exhibits anticonvulsant action in immature rats without a serious impairment of motor performance. Epilepsy Res 60 (2004) 17-26
24. Marino M.J., and Conn P.J. Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors. Curr Opin Pharmacol 6 (2006) 98-102
25. Mikami A., Masuoka T., Yasuda M., Yamamoto Y., and Kamei C. Participation of cholinergic system in memory deficits induced by blockade of hippocampal mGlu(1) receptors. Eur J Pharmacol 575 (2007) 82-86
26. Nagaraja R.Y., Grecksch G., Reymann K.G., Schroeder H., and Becker. A Group I metabotropic glutamate receptors interfere in different ways with pentylenetetrazole seizures, kindling, and kindling-related learning deficits. Naunyn Schmiedebergs Arch Pharmacol 370 (2004) 26-34
27. Pietraszek M., Sukhanov I., Maciejak P., Szyndler J., Gravius A., Wislowska A., et al. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Eur J Pharmacol 514 (2005) 25-34
28. Pin J.P., and Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34 (1995) 1-26
29. Ramos A., Berton O., Mormede P., and Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 85 (1997) 57-69
30. Rodgers R.J., Johnson N.J., Cole J.C., Dewar C.V., Kidd G.R., and Kimpson P.H. Plus-maze retest profile in mice: importance of initial stages of trial 1 and response to post-trial cholinergic receptor blockade. Pharmacol Biochem Behav 54 (1996) 41-50
31. Rodgers R.J., and Shepherd J.K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology 113 (1993) 237-242
32. Rossier J., and Schenk F. Olfactory and/or visual cues for spatial navigation through ontogeny: olfactory cues enable the use of visual cues. Behav Neurosci 117 (2003) 412-425
33. Sanchez C. 5-HT(1A) receptors play an important role in modulation of behavior of rats in a two-compartment black and white box. Behav Pharmacol 7 (1996) 788-797
34. Schachtman T.R., Bills C., Ghinescu R., Murch K., Serfozo P., and Simonyi A. MPEP, a selective metabotropic glutamate receptor 5 antagonist, attenuates conditioned taste aversion in rats. Behav Brain Res 141 (2003) 177-182
35. Simonyi A., Schachtman T.R., and Christoffersen G.R. The role of metabotropic glutamate receptor 5 in learning and memory processes. Drug News Perspect 18 (2005) 353-361
36. Spooren W., and Gasparini F. mGlu5 receptor antagonists: a novel class of anxiolytics?. Drug News Perspect 17 (2004) 251-257
37. Spooren W.P., Vassout A., Neijt H.C., Kuhn R., Gasparini F., Roux S., et al. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 295 (2000) 1267-1275
38. Takao K., and Miyakawa T. Light/dark transition test for mice. J Vis Exp (2006) 104
39. Tatarczynska E., Klodzinska A., Kroczka B., Chojnacka-Wojcik E., and Pilc A. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology 158 (2001) 94-99
40. Tonkiss J., Harrison R.H., and Galler J.R. Differential effects of prenatal protein malnutrition and prenatal cocaine on a test of homing behavior in rat pups. Physiol Behav 60 (1996) 1013-1018
41. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44 (1993) 463-469
42. Venerosi A., Valanzano A., Alleva E., and Calamandrei G. Prenatal exposure to anti-HIV drugs: neurobehavioral effects of zidovudine (AZT) + lamivudine (3TC) treatment in mice. Teratology 63 (2001) 26-37
43. West G.L., Sobotka T.J., Brodie R.E., Mills-Smith M.C., and Quander D.Y. Multipup homing: a rapid test for olfactory discrimination in neonatal rats. Neurobehav Toxicol Teratol 8 (1986) 293-296
44. Witkin J.M., Marek G.J., Johnson B.G., and Schoepp D.D. Metabotropic glutamate receptors in the control of mood disorders. CNS Neurol Disord Drug Targets 6 (2007) 87-100